Kane Biotech Inc. KNBIF
0.02 USD 0.00 (+0.00%)
Regular-session close
0.0215 Day range 0.0215
0.0157 52-week range 0.0331
- YTD
- -12.03%
- 1 year
- -4.10%
News
globenewswire.com Kane Announces Publication of Real-World Evidence in the International Wound Journal Study reports improvements across multiple wound-healing outcomes associated with adjunctive use of revyve® Antimicrobial Wound Gel Study reports improvements across multiple wound-healing outcomes…
globenewswire.com Kane Engages Independent Trading Group as Market Maker Agreement intended to support an orderly market and improve liquidity in Kane Biotech's common shares Agreement intended to support an orderly market and improve liquidity in Kane Biotech's common…
globenewswire.com Kane Biotech Signs Distribution Agreement with The Stevens Company Expands Kane Biotech's commercial footprint and access to the revyve ® product line across Canada
globenewswire.com Kane to Showcase revyve® at Wounds Canada National Hybrid Conference Engaging Canadian wound-care professionals, presenting data and discussing biofilm management in clinical practice WINNIPEG, Manitoba, Oct. 19, 2026 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE)…
globenewswire.com Kane Launches New Corporate Brand and Redesigned Website Refreshed identity reflects Kane's focus on clinical biofilm science, advanced wound care and commercialization Refreshed identity reflects Kane's focus on clinical biofilm science, advanced wound…
globenewswire.com Kane Biotech Announces $250,000 Insider Loan Unsecured, non-interest-bearing loan provides additional working capital support Unsecured, non-interest-bearing loan provides additional working capital support
globenewswire.com Kane Biotech to Present Clinical Data and Showcase revyve® Product Line at SAWC Fall 2026 Company to engage with wound-care professionals and meet with existing and prospective distribution partners Company to engage with wound-care professionals and meet with existing and prospective…
seekingalpha.com Kane Biotech Inc. (KNE:CA) Shareholder/Analyst Call Transcript Kane Biotech Inc. (KNE:CA) Shareholder/Analyst Call Transcript
globenewswire.com Kane Biotech to Host Commercial Update Webcast on September 16 Board Chair Philip Renaud, leading wound-care surgeon Dr. John C. Lantis and Interim CEO Dr. Robert Huizinga to discuss Kane's commercial progress, clinical relevance and operational priorities Board…
globenewswire.com Kane Biotech Announces Second Quarter 2026 Financial Results WINNIPEG, Manitoba, Aug. 27, 2026 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE) (the “Company”, “Kane” or “Kane Biotech”) announces today its second quarter 2026 financial results.
globenewswire.com Kane Biotech Announces Engagement of DNA Advisors DNA Advisors brings expertise in capital markets, strategic transactions, partnerships, and growth initiatives DNA Advisors brings expertise in capital markets, strategic transactions, partnerships,…
globenewswire.com Kane Biotech Announces Results of Annual and Special Meeting of Shareholders WINNIPEG, Manitoba, July 02, 2026 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE) (the “Company”, “Kane” or “Kane Biotech”) the voting results from its annual and special meeting of shareholders…
seekingalpha.com Kane Biotech Inc. (KNE:CA) Shareholder/Analyst Call Prepared Remarks Transcript Kane Biotech Inc. (KNE:CA) Shareholder/Analyst Call Prepared Remarks Transcript
globenewswire.com Kane Biotech Announces Grant of Stock Options Not for distribution to U.S. news wire services or dissemination in the United States WINNIPEG, Manitoba, May 29, 2026 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE) (“Kane Biotech”, “Kane” or the…
globenewswire.com Kane Biotech Announces First Quarter 2026 Financial Results WINNIPEG, Manitoba, May 28, 2026 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE) (the “Company”, “Kane” or “Kane Biotech”) announces today its first quarter 2026 financial results.
globenewswire.com Kane Biotech Announces the Oversubscription and Closing of Private Placement Offering Not for distribution to U.S. news wire services or dissemination in the United States WINNIPEG, Manitoba, May 26, 2026 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE) (the “Company”, “Kane” or…
globenewswire.com Kane Biotech Presents Data To Global Wound Care Community at WCET®–NSWOCC® 2026 Joint Congress Case study presented highlighted clinical experience with revyve® in complex wound care Case study presented highlighted clinical experience with revyve® in complex wound care
globenewswire.com Kane Biotech Announces New Private Placement Offering Not for distribution to U.S. news wire services or dissemination in the United States WINNIPEG, Manitoba, May 07, 2026 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE) (“Kane Biotech”, “Kane” or the…
globenewswire.com Kane Biotech Announces Fourth Quarter and Full Year 2025 Financial Results WINNIPEG, Manitoba, April 23, 2026 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE) (the “Company”, “Kane” or “Kane Biotech”) announces today its fourth quarter and full year 2025 financial results.
globenewswire.com Kane Biotech Announces Publication in Frontiers in Antibiotics Highlighting Advancements in Treating Antibiotic Tolerant Biofilms WINNIPEG, Manitoba, March 17, 2026 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE) (“Kane Biotech” or “Kane”) announces that Frontiers in Antibiotics has published a peer-reviewed article authored…
benzinga.com Stocks That Hit 52-Week Highs On Tuesday 
benzinga.com Stocks That Hit 52-Week Highs On Friday 
benzinga.com Stocks That Hit 52-Week Highs On Tuesday